Bristol Myers Squibb announced positive data from two separate Phase III clinical trials of the company’s checkpoint inhibitor Opdivo (nivolumab).

Deciphera Pharmaceuticals Inc.’s shares more than doubled after the drugmaker said a late-stage study met the main goal of helping stomach cancer patients live longer without their disease worsening.

Eli Lilly and Co.’s combination cancer treatment met the main goal of a late-stage clinical trial in testing on patients with a form of lung cancer, the drugmaker announced.

Cancer will claim the lives of 9.6 million people in 2018, accounting for one in eight of all deaths among men and one in 11 among women, the WHO’s cancer research agency said.

South Korea’s Samsung Bioepis said the U.S. FDA accepted for review its copy of Roche’s blockbuster breast cancer drug Herceptin for potential approval.